RegeneRx Biopharmaceuticals, Inc. RGRX
0.00 USD 0.00 (+0.00%)
At closeNov 6, 2026, 4:00 PM EST
0.161 Day range 0.161
0.0002 52-week range 0.163
- YTD
- +266.67%
- 1 year
- -99.32%
Revenue & Expenses
Latest period ending Dec 31, 2022 · select a line to chart its full history
Income statement
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 76.76K | 76.76K | 76.76K | 76.76K | 69.67K | |
| 76.76K | 76.76K | 76.76K | 76.76K | 69.67K | |
| -1.40M | -1.33M | -1.29M | -1.26M | -1.32M | |
| -1.73M | -1.60M | -1.52M | -1.40M | -1.99M | |
| -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
Balance sheet
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 290.89K | 1.23M | 427.90K | 639.92K | 237.26K | |
| 382.18K | 1.28M | 551.79K | 711.76K | 281.04K | |
| 3.83M | 3.51M | 3.38M | 3.05M | 2.49M | |
| 1.45M | 1.16M | 1.03M | 735.08K | 54.75K | |
| -3.45M | -2.23M | -2.82M | -2.34M | -2.21M |
Cash flow
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| -940.72K | -990.30K | -1.01M | -1.14M | -888.29K | |
| -940.72K | 803.71K | -212.02K | 402.65K | 55.55K |